Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
216 studies found for:    Open Studies | "Fatty Acids, Omega-3"
Show Display Options
Rank Status Study
21 Recruiting OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer
Condition: Pediatric Cancer
Intervention: Dietary Supplement: Omega-3 enriched fruit juice
22 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
23 Unknown  Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque
Condition: Acute Coronary Syndrome
Interventions: Drug: Intensive lipid lowering plus Omega3-fatty acid;   Drug: Moderate lipid lowering plus Omega3-fatty acid;   Drug: Intensive lipid lowering plus placebo;   Drug: Moderate lipid lowering plus placebo
24 Recruiting Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
Condition: Inflammatory Responses
Interventions: Drug: 4 g prescription omega-3 concentrate;   Drug: Placebo
25 Recruiting Effects of Marine n-3 Fatty Acids on Heart Rate Variability and Arrhythmias in Patients Receiving Chronic Dialysis
Conditions: Kidney Failure Chronic;   Arrhythmias Cardiac
Interventions: Dietary Supplement: dietary supplement: n-3 PUFA;   Dietary Supplement: olive oil
26 Recruiting Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents
Conditions: Obesity;   Insulin Resistance
Interventions: Dietary Supplement: Omega3 and an hypocaloric diet.;   Dietary Supplement: Sunflower oil with an hypocaloric diet.
27 Recruiting n-3 PUFA for Vascular Cognitive Aging
Conditions: Age Related Cognitive Decline;   Alzheimer's Disease;   Vascular Dementia;   Endothelial Dysfunction;   Executive Dysfunction
Interventions: Drug: Omega 3 PUFA;   Drug: Placebo
28 Not yet recruiting Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognition
Interventions: Drug: Alpha lipoic acid and omega-3 fatty acids;   Drug: Placebo
29 Recruiting The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Omega 3;   Other: Physical Training
30 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
31 Recruiting Omega-3 Dietary Supplements in Schizophrenia
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Bipolar I
Interventions: Drug: Risperidone;   Drug: Omega-3 capsules;   Drug: Amber 50/50 Soybean/Corn Placebo
32 Not yet recruiting Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
Condition: Morbid Obesity
Interventions: Drug: Omega-3 fatty acid capsules;   Behavioral: Low calorie diet
33 Unknown  Effect of Omega-3 Fatty Acid on Vitamin D Activation
Conditions: Hemodialysis Patients;   Vitamin D Insufficiency;   Vitamin D Deficiency
Interventions: Drug: Omega-3 fatty acid ethylester 90;   Other: Olive oil;   Other: cholecalciferol
34 Not yet recruiting Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
Condition: Whole Body Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
35 Not yet recruiting Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
Conditions: Traumatic Brain Injury;   Substance Abuse;   Substance Dependence
Interventions: Drug: Citicoline;   Drug: Omega-3;   Other: Rice bran oil;   Other: Microcrystalline Cellulose
36 Unknown  The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism
Condition: Skeletal Muscle Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
37 Recruiting Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Dietary Supplement: Omega-3 Fatty Acids;   Dietary Supplement: Medium Chain Triglycerides
38 Recruiting Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Conditions: Coronary Heart Disease;   Metabolic Syndrome
Intervention: Dietary Supplement: Omega 3 acid ethyl esters
39 Unknown  Feasibility of Omega-3 Supplementation for Children With Language Impairments
Condition: Language Impairment
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
40 Unknown  Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
Condition: Autism
Interventions: Dietary Supplement: Omega 3 fatty acids;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years